BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19691261)

  • 1. Prognostic relevance of F-18 fluorodeoxyglucose positron emission tomography and computed tomography in molar pregnancy before evacuation.
    Ak I; Ozalp S
    J Reprod Med; 2009 Jul; 54(7):441-6. PubMed ID: 19691261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Term delivery of a complete hydatidiform mole with a coexisting living fetus followed by successful treatment of maternal metastatic gestational trophoblastic disease.
    Peng HH; Huang KG; Chueh HY; Adlan AS; Chang SD; Lee CL
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):397-400. PubMed ID: 25286799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choriocarcinoma with pulmonary metastasis: report of a case of successful treatment with serial FDG-PET follow-up.
    Chang WC; Hung YC; Shen HP; Kao CH
    J Reprod Med; 2007 May; 52(5):450-2. PubMed ID: 17583253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinics in diagnostic imaging (9). Gestational trophoblastic disease with liver metastases.
    Helpert C; Peh WC; Ng TY
    Singapore Med J; 1996 Feb; 37(1):103-6. PubMed ID: 8783925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late spontaneous resolution of persistent molar pregnancy.
    Taylor F; Short D; Harvey R; Winter MC; Tidy J; Hancock BW; Savage PM; Sarwar N; Seckl MJ; Coleman RE
    BJOG; 2016 Jun; 123(7):1175-81. PubMed ID: 26774079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C; Colau JC
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 FDG PET/CT findings of a case of complete hydatidiform mole.
    Suga K; Nawata S; Kawakami Y; Hiyama A; Hori K; Matsunaga N
    Clin Nucl Med; 2009 May; 34(5):314-5. PubMed ID: 19387215
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial hCG and ultrasound measurements for predicting malignant potential in multiple pregnancies associated with complete hydatidiform mole: a report of 2 cases.
    Steigrad SJ; Robertson G; Kaye AL
    J Reprod Med; 2004 Jul; 49(7):554-8. PubMed ID: 15305827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of pre-evacuation ultrasound examination in histologically confirmed hydatidiform mole in missed abortion.
    Tang Y; Zhu C; Zhu C; Liang F; Lee A; Yao X; Chen Q
    BMC Womens Health; 2020 Sep; 20(1):196. PubMed ID: 32912152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study.
    Chang TC; Yen TC; Li YT; Wu YC; Chang YC; Ng KK; Jung SM; Wu TI; Lai CH
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):156-63. PubMed ID: 16220307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.